Patents by Inventor Evelyn Degenhard

Evelyn Degenhard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20240109964
    Abstract: The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the administration of a pharmaceutical composition comprising a CD19xCD3 bispecific single chain antibody construct to an adult patient in the need thereof.
    Type: Application
    Filed: February 3, 2023
    Publication date: April 4, 2024
    Inventors: Gerhard Zugmaier, Evelyn Degenhard
  • Treatment of acute lymphoblastic leukemia
    Patent number: 11597766
    Abstract: The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the administration of a pharmaceutical composition comprising a CD19×CD3 bispecific single chain antibody construct to an adult patient in the need thereof.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: March 7, 2023
    Assignee: AMGEN RESEARCH (MUNICH) GMBH
    Inventors: Gerhard Zugmaier, Evelyn Degenhard
  • TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20190300609
    Abstract: The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the administration of a pharmaceutical composition comprising a CD19×CD3 bispecific single chain antibody construct to an adult patient in the need thereof.
    Type: Application
    Filed: December 13, 2018
    Publication date: October 3, 2019
    Inventors: Gerhard Zugmaier, Evelyn Degenhard
  • TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20130323247
    Abstract: The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the administration of a pharmaceutical composition comprising a CD19xCD3 bispecific single chain antibody construct to an adult patient in the need thereof.
    Type: Application
    Filed: November 6, 2009
    Publication date: December 5, 2013
    Inventors: Gerhard Zugmaier, Evelyn Degenhard